VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, January 7, 2026
Stock Comparison
VINCI SA vs Johnson & Johnson
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
VINCI SA
DG · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Johnson & Johnson
JNJ · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Johnson & Johnson's moat claims, evidence, and risks.
View JNJ analysisComparison highlights
- Moat score gap: Johnson & Johnson leads (61 / 100 vs 57 / 100 for VINCI SA).
- Segment focus: VINCI SA has 7 segments (44.4% in VINCI Construction); Johnson & Johnson has 2 segments (64.1% in Innovative Medicine).
- Primary market structure: Competitive vs Competitive. Pricing power: Weak vs Moderate.
- Moat breadth: VINCI SA has 7 moat types across 2 domains; Johnson & Johnson has 5 across 3.
Primary market context
VINCI SA
VINCI Construction
Construction and civil engineering contracting (buildings, infrastructure and specialty networks)
Global
Public-sector project owners and private developers/industrial clients
General contractor / civil engineering contractor
44.4%
Johnson & Johnson
Innovative Medicine
Branded prescription pharmaceuticals (biopharma)
Global
Wholesalers, hospitals, retailers, healthcare professionals, payers
Drug discovery, development, manufacturing, commercialization
64.1%
Side-by-side metrics
Moat coverage
Shared moat types
VINCI SA strengths
Johnson & Johnson strengths
Segment mix
VINCI SA segments
Full profile >VINCI Autoroutes
Monopoly
VINCI Airports
Oligopoly
Other concessions (incl. VINCI Highways and PPP assets)
Competitive
VINCI Energies
Competitive
Cobra IS
Competitive
VINCI Construction
Competitive
VINCI Immobilier
Competitive
Johnson & Johnson segments
Full profile >Innovative Medicine
Competitive
MedTech
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.